文献速递头颈部肿瘤放疗姑息放疗与转移瘤放疗物理与技术

AMORE方案作为复发头颈部横纹肌肉瘤儿童及年轻成人的挽救治疗

AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
PubMed 文献 · Radiother Oncol · 2018-12-17

本研究分析了18例既往接受过外照射放疗后复发的头颈部横纹肌肉瘤患者,接受挽救性AMORE治疗(消融手术、模具技术近距离放疗和手术重建)。局部控制率为67%,5年总生存率为54%(95%CI 31-78%)。作者认为AMORE是可行的局部治疗选择,并鼓励医生考虑用于此类患者。

要点

  • 18例既往EBRT后复发HNRMS患者接受挽救AMORE,局部控制率67%,5年OS 54%(95%CI 31-78%)。
  • 中位随访8.6年,眼眶RMS 6/7存活,PM RMS 3/9存活,HN-nonPM RMS 0/2存活。
  • 作者认为AMORE是可行有效的局部治疗,鼓励医生考虑用于既往EBRT后复发HNRMS。

核心结论

  • 挽救性AMORE治疗是可行的局部治疗方式,即使既往接受过外照射放疗。
  • 作者鼓励医生考虑对既往EBRT后复发的头颈部横纹肌肉瘤患者使用挽救性AMORE治疗。

研究设计与样本

  • 本研究分析了既往EBRT后复发头颈部横纹肌肉瘤、且挽救性AMORE治疗被认为可行的患者,包括脑膜旁、头颈部非脑膜旁和眼眶部位。
  • AMORE治疗由消融手术、模具技术近距离放疗和手术重建组成。
  • 共18例患者接受挽救性AMORE治疗:9例复发脑膜旁横纹肌肉瘤,2例复发头颈部非脑膜旁横纹肌肉瘤,7例复发眼眶横纹肌肉瘤。

主要发现

  • 局部控制率为67%,5年总生存率为54%(95%CI 31-78%)。
  • 中位随访8.6年,脑膜旁横纹肌肉瘤3/9例存活,头颈部非脑膜旁横纹肌肉瘤0/2例存活,眼眶横纹肌肉瘤6/7例存活。
  • 1例脑膜旁横纹肌肉瘤患者存活超过5年后死于第二原发癌。
  • 6例患者出现局部复发(其中1例同时出现远处转移),2例患者出现远处转移。

临床怎么用

  • 作者认为挽救性AMORE治疗有时是复发头颈部横纹肌肉瘤患者唯一的治愈选择,鼓励医生考虑对既往EBRT后复发患者使用挽救性AMORE治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Survival after relapse of head and neck rhabdomyosarcoma (HNRMS) after prior external beam radiotherapy (EBRT) is poor, since options for adequate local treatment are often lacking. In this study we describe our experience with salvage AMORE in patients with relapsed HNRMS after prior EBRT. MATERIALS AND METHODS: Patients with relapsed HNRMS after prior EBRT in which salvage AMORE treatment was considered feasible were analysed; this includes patients with parameningeal, head and neck non-parameningeal and orbital localization. AMORE treatment consisted of Ablative surgery, MOuld technique brachytherapy and surgical REconstruction. RESULTS: In total 18 patients received salvage AMORE treatment; nine patients had relapsed parameningeal (PM) RMS, two patients had relapsed head and neck non-parameningeal RMS (HN-nonPM) and seven patients had relapsed orbital RMS. Local control rate was 67% and 5-year overall survival was 54% (95% confidence interval: 31-78%); 3/9 patients with PM RMS, 0/2 patients with HN-nonPM RMS and 6/7 patients with orbital RMS were alive after a median follow-up of 8.6 years. One patient with PM RMS survived more than 5 years after which he died from a secondary cancer. Six patients developed a local relapse (of which one patient also developed a distant metastasis) and two patients developed distant metastases. CONCLUSIONS: Salvage AMORE treatment is a feasible and effective local therapy approach even after prior EBRT. Since salvage AMORE treatment is sometimes the only curative option in patient with relapsed HNRMS, we encourage physicians to consider salvage AMORE treatment for patients with relapsed HNRMS after prior EBRT.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Vaarwerk B, Hol MLF, Schoot RA, et al. AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma. Radiother Oncol. 2018. PMID: 30773183. doi:10.1016/j.radonc.2018.10.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。